The REDUCE EU Study - Endobronchial Thermal Liquid Ablation (ETLA) for the Treatment of Emphysema

Clinical trial NCT06655428 · RECRUITING

Trial details

NCT number: NCT06655428
Sponsor: Morair Medtech, LLC
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Emphysema or COPD Emphysema Emphysema, Pulmonary COPD COPD (Chronic Obstructive Pulmonary Disease)

Start date: 2025-01-10
Primary completion: 2026-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.